OptimizeRx's TelaRep™ Recognized as One of the Most Innovative Products for Life Sciences by PM360GlobeNewsWire • 12/11/20
OptimizeRx CEO, William Febbo, to Speak at Bank of America 4th Annual HCIT and Digital Health Symposium Today, December 9, 2020GlobeNewsWire • 12/09/20
OptimizeRx Partners with Komodo Health to Expand Life Sciences Support at Point-of-CareGlobeNewsWire • 12/07/20
OptimizeRx Launches AI-Powered Real-World Evidence Solution on Its Point-of-Care PlatformGlobeNewsWire • 12/01/20
OptimizeRx Ranked Number 432 Fastest-Growing Company in North America on Deloitte's 2020 Technology Fast 500™GlobeNewsWire • 11/18/20
OptimizeRx and Questex's Fierce Life Sciences Tackle Industry's Top Challenges in Design Thinking Event, Innovate4OutcomesGlobeNewsWire • 11/17/20
Point-of-Care Industry Expert, Angelo Campano, Joins OptimizeRx Executive Leadership as Senior Vice President and Principal of Agency ChannelsGlobeNewsWire • 11/11/20
OptimizeRx Corporation (OPRX) CEO William Febbo on Q3 2020 Results - Earnings Call TranscriptSeeking Alpha • 11/10/20
OptimizeRx Third Quarter 2020 Revenue Up 110% to Record $10.5 Million, Driving Non-GAAP Net Income of $1.1 million or $0.07 Per ShareGlobeNewsWire • 11/09/20
OptimizeRx Sets Third Quarter 2020 Conference Call for Monday, November 9, 2020 at 4:30 p.m. ETGlobeNewsWire • 10/26/20
OptimizeRx Expects Record Revenue Exceeding $10.0 Million in Q3 2020, up 100%GlobeNewsWire • 10/13/20
SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating OptimizeRx Corporation for Potential Breaches of Fiduciary Duty By Its Board of DirectorsPRNewsWire • 10/05/20
OptimizeRx Continues Webinar Series, Introducing Innovative Ideas for Transforming New Medication LaunchesGlobeNewsWire • 09/21/20
OptimizeRx Expands Direct-to-Patient Reach, Partnering with Epion Health to Provide Adherence and Affordability Support at Point-of-CareGlobeNewsWire • 09/15/20
OptimizeRx Enters Retail Pharmacies, Supporting Adherence by Bringing Prescription Savings Directly to Patients via Higi Smart Health StationsGlobeNewsWire • 08/20/20
OptimizeRx Corporation (OPRX) CEO William Febbo on Q2 2020 Results - Earnings Call TranscriptSeeking Alpha • 08/10/20
OptimizeRx Reports Second Quarter 2020 Revenue Up 25% to a Record $8.8 Million; First Half Revenue up 34% to Record $16.4 Million, with Accelerated Growth Expected in Second HalfGlobeNewsWire • 08/05/20